Abstract
Cardiac diastolic function and blood pressure are physiologically interconnected, making it difficult to isolate the genetic determinants of heart relaxation from the effects of systemic loading. This study utilized a cross-species approach, combining quantitative trait locus (QTL) mapping in rats with large-scale human genomic and imaging data from the UK Biobank. In rats, we identified a significant locus on chromosome 3, corresponding to the titin (Ttn) gene, that regulates left ventricular relaxation independently of blood pressure. In humans, rare titin truncating variants (TTNtv) were associated with a significantly increased risk of heart failure (HR 3.76) and impaired diastolic strain rates, even in individuals with normal systolic function. These findings establish titin as a primary genetic driver of diastolic function across species and a potential early marker for heart failure.
Introduction
Heart failure is a complex clinical syndrome often categorized by whether the primary defect lies in the heart's ability to pump blood (systolic function) or its ability to fill with blood (diastolic function). Diastolic dysfunction, characterized by increased myocardial stiffness and impaired relaxation, is a major contributor to heart failure with preserved ejection fraction (HFpEF). However, identifying the specific genetic drivers of diastolic function is challenging because it is "physiologically tangled" with blood pressure; chronic hypertension induces structural changes in the heart that mimic primary genetic stiffness. To address this, researchers sought to decouple these factors using a combination of controlled animal models and high-resolution human biobank data.
Decoupling Function from Pressure in Rat Models
To isolate intrinsic cardiac mechanics from systemic influences, the study employed an ex vivo Langendorff preparation using an F2 intercross of Brown Norway (BN) and Spontaneously Hypertensive Rat (SHR) strains. By perfusing the hearts outside the body, researchers could strictly control heart rate and loading conditions while measuring left ventricular relaxation ($dP/dt_{min}$) and contractility ($dP/dt_{max}$).
Quantitative Trait Locus (QTL) mapping revealed a single significant locus on chromosome 3 that reached genome-wide significance for relaxation. This locus, which encodes the Ttn gene, explained 21.8% of the variation in heart relaxation and 17.2% of the variation in contractility. Crucially, this genetic association remained significant regardless of the animal's baseline blood pressure, identifying titin as a primary regulator of the heart's "intrinsic" relaxation capacity.
Human Clinical Implications and the UK Biobank
The study translated these findings to humans by analyzing Whole Exome Sequencing (WES) data from 454,756 participants in the UK Biobank. The researchers focused on rare Titin Truncating Variants (TTNtv), which were found in approximately 1 in 270 participants (0.37%).
Clinical Outcomes
Carrying a TTNtv was strongly associated with adverse clinical outcomes:
- Heart Failure: A 3.76-fold increased risk (95% CI: 3.30-4.29).
- Major Adverse Cardiac Events (MACE): A 1.94-fold increased risk (95% CI: 1.78-2.12).
Subclinical Imaging Phenotypes
Using deep-learning algorithms to analyze Cardiac Magnetic Resonance (CMR) imaging in nearly 34,000 participants, the team identified a "silent" phase of heart disease. TTNtv carriers exhibited significantly lower Peak Early Diastolic Strain Rate (PDSR) across longitudinal, radial, and circumferential directions. Notably, these deficits in relaxation speed were present even in individuals with normal ejection fractions and no evidence of ventricular dilatation, suggesting that diastolic impairment is an early, subclinical marker of genetic heart disease.
The Molecular Spring
Titin is the largest protein in the human body, serving as a structural scaffold and a "molecular spring" within the sarcomere. It provides the passive recoil necessary for the heart to fill efficiently during diastole. This study reinforces the role of titin as a fundamental biological constant in mammalian cardiac mechanics. The fact that natural variations in Ttn affect function in both rats and humans suggests that the protein's mechanical properties are critical to maintaining healthy filling pressures.
Conclusion and Future Directions
This research demonstrates that titin variants impair myocardial relaxation and increase heart failure risk long before clinical symptoms like heart dilation appear. While the study is limited by the primarily European ancestry of the UK Biobank cohort, it opens new doors for therapeutic intervention. Because titin’s stiffness can be modulated by post-translational modifications (such as phosphorylation), future treatments could potentially "tune" the titin spring to alleviate diastolic dysfunction in patients with HFpEF, a condition that currently lacks diverse effective treatment options.
Summary updated